News
XS Innovations raises seed investment of EUR 1.1 m to accelerate development of vascular access device “the Dynamic AVF”
• Investment will accelerate development of a state-of-the-art vascular access device known as Dynamic AVF, to improve treatment for end-stage kidney disease patients
Spatium Medical B.V. raises 5 million to bring smart insufflation technology to operating rooms in europe and the United States
Rotterdam-based Spatium Medical B.V., a MedTech spin-off from Erasmus MC University Hospital, has successfully closed a €5 million funding round.
Applications for the Termeer Fellowship Class of 2025 will open from September 30th!
Are you an early-stage CEO of an early or non-profit biotech/life sciences organisation committed to developing potentially life-changing treatments for patients?
Pitching Applications for HealthTech Investor Summit Open Now!
Pitching applications are in full swing for the HealthTech Investor Summit in December!
Een kijkje achter de schermen bij de toekenningspartijen
De Nederlandse LSH-sector blinkt uit door de intensieve samenwerking met internationale topwetenschappers en de dynamische band tussen het bedrijfsleven en de academische wereld.
From lab to market: Irati's startup journey
“Even though it’s risky, I trust in my technology,” says Irati Beltrán Hernández, who is setting up a science startup with Sebas Pronk
Join the Dutch Lounge at Nordic Life Science Days 2024
The Nordic Life Science Days (NLSDays) is the premiere venue for doing business with Nordic life science companies and where new international connections are made in the Nordics.
XS-Innovations is hiring: Senior Design Engineer
Globally, 2.5 million patients rely on kidney dialysis machines three times a week as their lifeline. The high blood flow needed for these three-hour sessions is achieved through a surgically created connection between an artery and a vein in the arm.
ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech
Leiden, 12th July 2024 – ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation, is proud to share that it has closed its latest funding round with Capricorn Partners and T
Call for startups: pitch opportunity at Investors Forum
Young companies active in the life sciences industry, pitch your company and/or innovations at the Dutch Life Sciences conference. Increase your visibility, earn PR and connect to collaboration partners and investors.